ArticlePDF Available

The Importance of Halotherapy in the Treatment of COVID-19 Related Diseases

Authors:
  • Bilecik Şeyh Edebali University
  • Bilecik Şeyh Edebali Üniversitesi

Abstract

Treatment and post-treatment rehabilitation of COVID-19, which first appeared in Wuhan, China at the end of 2019, causing hundreds of thousands of people to die, has become very important for both patients and scientists. Some chronic health problems, especially in healing patients, have led to the emergence of alternative treatment methods. Significant studies have been conducted on COVID-19 triggering chronic respiratory diseases in patients recovered because of the effects on the respiratory tract. In some studies, it was found that individuals who recovered could not use the functions of the lung with their pre-disease capacity. Halotherapy, which is a treatment method applying by be delivered a fine powder to the upper part of the lower respiratory tract of a person, is a natural and reliable therapy method for respiratory infections, asthma, allergic and chronic bronchitis, colds, pharyngitis, rhinitis, tonsillitis, chronic obstructive pulmonary disease, and various skin diseases. Halotherapy has an important place in alternative medicine. Many studies have been carried out on the benefit of Halotherapy, which is considered both Salt Therapy and Cave Therapy, in chronic respiratory diseases. In this context, it is considered that Halotherapy can be useful in the treatment of chronic respiratory diseases of individuals with COVID-19 disease in our study based on these studies. Also, scientific studies are recommended treating patients with COVID-19 in areas where salt therapy and speleotherapy are involved in the treatment of chronic respiratory diseases.
Volume 11 Number 4 December 2020 em00754
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 1 / 7
RESEARCH ARTICLE
Treatment and post-treatment rehabilitation of COVID-19, which first appeared in Wuhan,
China at the end of 2019, causing hundreds of thousands of people to die, has become very
important for both patients and scientists. Some chronic health problems, especially in healing
patients, have led to the emergence of alternative treatment methods. Significant studies have
been conducted on COVID-19 triggering chronic respiratory diseases in patients recovered
because of the effects on the respiratory tract. In some studies, it was found that individuals
who recovered could not use the functions of the lung with their pre-disease capacity.
Halotherapy, which is a treatment method applying by be delivered a fine powder to the upper
part of the lower respiratory tract of a person, is a natural and reliable therapy method for
respiratory infections, asthma, allergic and chronic bronchitis, colds, pharyngitis, rhinitis,
tonsillitis, chronic obstructive pulmonary disease, and various skin diseases. Halotherapy has
an important place in alternative medicine. Many studies have been carried out on the benefit
of Halotherapy, which is considered both Salt Therapy and Cave Therapy, in chronic respiratory
diseases. In this context, it is considered that Halotherapy can be useful in the treatment of
chronic respiratory diseases of individuals with COVID-19 disease in our study based on these
studies. Also, scientific studies are recommended treating patients with COVID-19 in areas
where salt therapy and speleotherapy are involved in the treatment of chronic respiratory
diseases.
Keywords: COVID-19, halotherapy, respiratory diseases
Halotherapy in the Treatment of COVID-19
2 / 7 | Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. www.jceionline.org
Figure 1. Types of Halotherapy
Halotherapy in the Treatment of COVID-19
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 3 / 7
Halotherapy in the Treatment of COVID-19
4 / 7 | Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. www.jceionline.org
Halotherapy in the Treatment of COVID-19
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 5 / 7
Halotherapy in the Treatment of COVID-19
6 / 7 | Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. www.jceionline.org
Halotherapy in the Treatment of COVID-19
www.jceionline.org Copyright © 2020 by Authors. Licensee Modestum. OPEN ACCESS for all. | 7 / 7
Article
Catalysis is becoming a strategic area of science because it represents a new way to meet the challenges of energy and sustain ability. In recent times, silver nanoparticles (Ag NPs) were widely utilized as catalyst in a diverse range of organic transformations such as coupling, reduction and multicomponent reactions. In this review, we present recent developments in the catalytic application of silver nanoparticles (Ag NPs) in chemical reactions.
Article
Heterocycles are an integral and important component in the structure of most drugs, natural products and biologically active compounds. Research on transition metal catalysts has recently received a lot of attention due to their unique properties. In recent times, the immobilization of metallic complexes on magnetic nanoparticles has presented as an interesting and efficient catalytic strategy for the synthesis of heterocyclic molecules. In this review, we focused on the constructions of metallic complexes immobilized on magnetic nanoparticles and investigated their catalytic activity in the synthesis of a library of heterocyclic compounds.
Article
The pyran scaffolds are present in many natural products, pharmaceutical and bioactive molecules. These valuable bioactivities have prompted synthetic chemists to develop novel, green and efficient catalytic systems for the synthesis of pyran scaffolds. Nowadays, magnetic nanocatalysts have opened up new chapters for generating numerous products with extremely high activity and selectivity, low energy consumption and long life time. The present review summarizes the application of magnetic nanomaterials as efficient magnetically recoverable nanocatalysts for the synthesis of diverse biologically relevant pyran scaffolds reported so far.
Article
Full-text available
In late December 2019, a cluster of cases with 2019 Novel Coronavirus pneumonia (SARS-CoV-2) in Wuhan, China, aroused worldwide concern. Previous studies have reported epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19). The purpose of this brief review is to summarize those published studies as of late February 2020 on the clinical features, symptoms, complications, and treatments of COVID-19 and help provide guidance for frontline medical staff in the clinical management of this outbreak.
Article
Full-text available
Background Chest CT is used to assess the severity of lung involvement in COVID-19 pneumonia. Purpose To determine the change in chest CT findings associated with COVID-19 pneumonia from initial diagnosis until patient recovery. Materials and Methods This retrospective review included patients with RT-PCR confirmed COVID-19 infection presenting between 12 January 2020 to 6 February 2020. Patients with severe respiratory distress and/ or oxygen requirement at any time during the disease course were excluded. Repeat Chest CT was obtained at approximately 4 day intervals. The total CT score was the sum of lung involvement (5 lobes, score 1-5 for each lobe, range, 0 none, 25 maximum) was determined. Results Twenty one patients (6 males and 15 females, age 25-63 years) with confirmed COVID-19 pneumonia were evaluated. These patients under went a total of 82 pulmonary CT scans with a mean interval of 4±1 days (range: 1-8 days). All patients were discharged after a mean hospitalized period of 17±4 days (range: 11-26 days). Maximum lung involved peaked at approximately 10 days (with the calculated total CT score of 6) from the onset of initial symptoms (R2=0.25), p<0.001). Based on quartiles of patients from day 0 to day 26 involvement, 4 stages of lung CT were defined: Stage 1 (0-4 days): ground glass opacities (GGO) in 18/24 (75%) patients with the total CT score of 2±2; (2)Stage-2 (5-8d days): increased crazy-paving pattern 9/17 patients (53%) with a increase in total CT score (6±4, p=0.002); (3) Stage-3 (9-13days): consolidation 19/21 (91%) patients with the peak of total CT score (7±4); (4) Stage-4 (≥14 days): gradual resolution of consolidation 15/20 (75%) patients with a decreased total CT score (6±4) without crazy-paving pattern. Conclusion In patients recovering from COVID-19 pneumonia (without severe respiratory distress during the disease course), lung abnormalities on chest CT showed greatest severity approximately 10 days after initial onset of symptoms.
Article
Full-text available
The current outbreak of the novel coronavirus Covid‐19 (coronavirus disease 2019; previously 2019‐nCoV), epi‐centered in Hubei Province of the People's Republic of China, has spread to many other countries. On January 30, 2020, the WHO Emergency Committee declared a global health emergency based on growing case notification rates at Chinese and international locations. The case detection rate is changing hourly and daily and can be tracked in almost real time on website provided by Johns Hopkins University [1] and other websites. As of early February 2020, China bears the large burden of morbidity and mortality, whereas the incidence in other Asian countries, in Europe and North America remains low so far.
Preprint
Full-text available
Background: Since December 2019, acute respiratory disease (ARD) due to 2019 novel coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We sought to delineate the clinical characteristics of these cases. Methods: We extracted the data on 1,099 patients with laboratory-confirmed 2019-nCoV ARD from 552 hospitals in 31 provinces/provincial municipalities through January 29th, 2020. Results: The median age was 47.0 years, and 41.90% were females. Only 1.18% of patients had a direct contact with wildlife, whereas 31.30% had been to Wuhan and 71.80% had contacted with people from Wuhan. Fever (87.9%) and cough (67.7%) were the most common symptoms. Diarrhea is uncommon. The median incubation period was 3.0 days (range, 0 to 24.0 days). On admission, ground-glass opacity was the typical radiological finding on chest computed tomography (50.00%). Significantly more severe cases were diagnosed by symptoms plus reverse-transcriptase polymerase-chain-reaction without abnormal radiological findings than non-severe cases (23.87% vs. 5.20%, P<0.001). Lymphopenia was observed in 82.1% of patients. 55 patients (5.00%) were admitted to intensive care unit and 15 (1.36%) succumbed. Severe pneumonia was independently associated with either the admission to intensive care unit, mechanical ventilation, or death in multivariate competing-risk model (sub-distribution hazards ratio, 9.80; 95% confidence interval, 4.06 to 23.67). Conclusions: The 2019-nCoV epidemic spreads rapidly by human-to-human transmission. Normal radiologic findings are present among some patients with 2019-nCoV infection. The disease severity (including oxygen saturation, respiratory rate, blood leukocyte/lymphocyte count and chest X-ray/CT manifestations) predict poor clinical outcomes.
Article
In the event of a global infectious pandemic, drastic measures may be needed that limit or require adjustment of ambulatory allergy services. However, no rationale for how to prioritize service shut down and patient care exists. A consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily triage allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted modified Delphi methodology to achieve consensus. During the ongoing pandemic while social distancing is being encouraged, most allergy/immunology care could be postponed/delayed or handled through virtual care. With the exception of many patients with primary immunodeficiency, patients on venom immunotherapy, and patients with asthma of a certain severity, there is limited need for face-to-face visits under such conditions. These suggestions are intended to help provide a logical approach to quickly adjust service to mitigate risk to both medical staff and patients. Importantly, individual community circumstances may be unique and require contextual consideration. The decision to enact any of these measures rests with the judgment of each clinician and individual health care system. Pandemics are unanticipated, and enforced social distancing/quarantining is highly unusual. This expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.